Dr. Michael Schraeml

Dr. Michael Schraeml

Board Member

Dr. Schraeml obtained his PhD in Biotechnology at the Martin Luther Universität, Halle-Wittenberg, after which he joined Scil Proteins GmbH in the position of Head of Affilin technology (development of artificial binding proteins). In 2007, he joined Roche Diagnostics GmbH, Penzberg, Germany, where started as Team Lead Biointeraction Analysis and currently holds the position of Director Antigen Design & Protein Expression Technologies. Dr. Schreaml has a vast experience in all facets of real time interaction measurement assays and label-free biosensing technologies, an area which he has been involved in since 1999.


Ruben van Harmelen

Ruben van Harmelen, MSc

Product Application Specialist

Ruben van Harmelen obtained his masters in Biomedical Engineering at the Univeristy of Groningen. As Product Application Specialist, his able to combine his in-depth knowledge of biology, engineering and product development and manages the assembly and deployability of Delta Diagnostics’ instruments. Ruben also delivers technical support to our customers.


Vanessa Jungbluth

Vanessa Jungbluth, Ph.D.

Assay Developer

Vanessa Jungbluth is a young researcher with more than 5 years of experience in the multi-disciplinary field of biosensors. She started her career at Philips Healthcare and the Austrian Institute of Technology, where she worked on optical biosensing for fast and reliable diagnosis of various medical conditions. As a MSCA fellow, she recently obtained her PhD degree in non-invasive cancer detection using plasmonic biosensing at the University of Catania in the framework of an H2020-MSCA-ITN-2017 funded project. Currently, Vanessa is working as assay developer for Delta Diagnostics, interacting with customers and partners, and expediting international collaborations.


Corné van den Kieboom

Corné van den Kieboom

Lead Assay Developer

Corné van den Kieboom has over 10 years of experience in assay development for molecular diagnostics. He obtained his PhD on novel diagnostic techniques and biomarker discovery at the Radboud University Medical Centre. After his PhD, he worked at Innosieve Diagnostics as lead assay developer and was responsible for test kit production scale-up. Currently, Corné focusses on bridging the gap between clinic and diagnostics developers. Early 2018, he founded The contract R&D and consultancy company “Inventin”. Over the years, Corné collaborated with many innovative players in the field of platform development, e.g. NXP Semiconductors, IMEC, Biocartis and BiosparQ.


Peter Harmsma

Peter Harmsma, Ph.D.

Manager Product Develoment

Peter Harmsma has been lead Sr. Scientist on integrated optics at the Netherlands Organisation for Applied Scientific Research – TNO for over 10 years. He holds a PhD in integrated optics, and was co-founder of the start-up company ThreeFive Photonics (Delft, 2000). This company commercialized the integrated optics technology developed at the Delft University of Technology for telecom applications. Peter is specialized in the design of integrated photonics chips, and in test and measurement strategies. He has an extensive network in the European (integrated) optics community, and has played an important role in several integrated photonics-related European projects. Together with Bart, Peter developed the technology that Delta Diagnostics commercializes within the Optic department of TNO.